img

Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2024

0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
According to Mr Accuracy reports’s new survey, global 0.9% Sodium Chloride Intravenous Infusion market is projected to reach US$ 1557.7 million in 2029, increasing from US$ 1241 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 0.9% Sodium Chloride Intravenous Infusion market research.
The sodium chloride injection bag market is primarily driven by its essential role in intravenous (IV) fluid therapy, making it a critical medical device in healthcare settings. These bags contain sterile saline solution, used for hydration, electrolyte balance, and dilution of medications, indispensable in various medical procedures, surgeries, and emergency care. The increasing prevalence of conditions requiring IV fluid administration, such as dehydration, infections, and trauma, fuels the demand for sodium chloride injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, supply chain disruptions and fluctuations in the availability and cost of raw materials can impact the production and distribution of sodium chloride injection bags, posing challenges for healthcare facilities in ensuring a stable supply for patient care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 0.9% Sodium Chloride Intravenous Infusion market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
B.Braun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical
Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottle

Segment by Application


Hospitals
Clinics
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 0.9% Sodium Chloride Intravenous Infusion report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 0.9% Sodium Chloride Intravenous Infusion Market Overview
1.1 Product Overview and Scope of 0.9% Sodium Chloride Intravenous Infusion
1.2 0.9% Sodium Chloride Intravenous Infusion Segment by Type
1.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2024-2034)
1.2.2 Flexible Bag
1.2.3 Plastic Bottles
1.2.4 Glass Bottle
1.3 0.9% Sodium Chloride Intravenous Infusion Segment by Application
1.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global 0.9% Sodium Chloride Intravenous Infusion Market Size Estimates and Forecasts
1.4.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue 2018-2029
1.4.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales 2018-2029
1.4.3 Global 0.9% Sodium Chloride Intravenous Infusion Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 0.9% Sodium Chloride Intravenous Infusion Market Competition by Manufacturers
2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Manufacturers (2018-2024)
2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Manufacturers (2018-2024)
2.3 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Manufacturers (2018-2024)
2.4 Global 0.9% Sodium Chloride Intravenous Infusion Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Product Type & Application
2.7 0.9% Sodium Chloride Intravenous Infusion Market Competitive Situation and Trends
2.7.1 0.9% Sodium Chloride Intravenous Infusion Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 0.9% Sodium Chloride Intravenous Infusion Players Market Share by Revenue
2.7.3 Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 0.9% Sodium Chloride Intravenous Infusion Retrospective Market Scenario by Region
3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 0.9% Sodium Chloride Intravenous Infusion Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2018-2029
3.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2018-2024
3.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2024-2029
3.3 Global 0.9% Sodium Chloride Intravenous Infusion Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2018-2029
3.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2018-2024
3.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2024-2029
3.4 North America 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.4.1 North America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.4.3 North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.5.1 Europe 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.5.3 Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.6.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.6.3 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.7.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.7.3 Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.8.3 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2018-2029)
4.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2018-2024)
4.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2024-2029)
4.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2018-2029)
4.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2018-2029)
4.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2018-2024)
4.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2024-2029)
4.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2018-2029)
4.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Type (2018-2029)
5 Segment by Application
5.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2018-2029)
5.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2018-2024)
5.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2024-2029)
5.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2018-2029)
5.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2018-2029)
5.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2018-2024)
5.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2024-2029)
5.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2018-2029)
5.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Kelun Group
6.1.1 Kelun Group Corporation Information
6.1.2 Kelun Group Description and Business Overview
6.1.3 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.1.5 Kelun Group Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Baxter 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Shijiazhuang No.4 Pharmaceutical
6.4.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
6.4.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
6.4.3 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.4.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Corporation Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.5.4 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Corporation Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.6.4 B.Braun 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Otsuka 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Cisen Pharmaceutical
6.8.1 Cisen Pharmaceutical Corporation Information
6.8.2 Cisen Pharmaceutical Description and Business Overview
6.8.3 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.8.5 Cisen Pharmaceutical Recent Developments/Updates
6.9 Hospira (ICU Medical)
6.9.1 Hospira (ICU Medical) Corporation Information
6.9.2 Hospira (ICU Medical) Description and Business Overview
6.9.3 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.9.5 Hospira (ICU Medical) Recent Developments/Updates
6.10 Huaren Pharmaceuticals
6.10.1 Huaren Pharmaceuticals Corporation Information
6.10.2 Huaren Pharmaceuticals Description and Business Overview
6.10.3 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.10.5 Huaren Pharmaceuticals Recent Developments/Updates
6.11 Zhejiang Chimin
6.11.1 Zhejiang Chimin Corporation Information
6.11.2 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.11.3 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.11.5 Zhejiang Chimin Recent Developments/Updates
6.12 Dubang Pharmaceutical
6.12.1 Dubang Pharmaceutical Corporation Information
6.12.2 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.12.3 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.12.5 Dubang Pharmaceutical Recent Developments/Updates
6.13 Guizhou Tiandi
6.13.1 Guizhou Tiandi Corporation Information
6.13.2 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.13.3 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.13.5 Guizhou Tiandi Recent Developments/Updates
6.14 Qidu Pharmaceutical
6.14.1 Qidu Pharmaceutical Corporation Information
6.14.2 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.14.3 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.14.5 Qidu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 0.9% Sodium Chloride Intravenous Infusion Industry Chain Analysis
7.2 0.9% Sodium Chloride Intravenous Infusion Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 0.9% Sodium Chloride Intravenous Infusion Production Mode & Process
7.4 0.9% Sodium Chloride Intravenous Infusion Sales and Marketing
7.4.1 0.9% Sodium Chloride Intravenous Infusion Sales Channels
7.4.2 0.9% Sodium Chloride Intravenous Infusion Distributors
7.5 0.9% Sodium Chloride Intravenous Infusion Customers
8 0.9% Sodium Chloride Intravenous Infusion Market Dynamics
8.1 0.9% Sodium Chloride Intravenous Infusion Industry Trends
8.2 0.9% Sodium Chloride Intravenous Infusion Market Drivers
8.3 0.9% Sodium Chloride Intravenous Infusion Market Challenges
8.4 0.9% Sodium Chloride Intravenous Infusion Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global 0.9% Sodium Chloride Intravenous Infusion Market Competitive Situation by Manufacturers in 2022
Table 4. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) of Key Manufacturers (2018-2024)
Table 5. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Manufacturers (2018-2024)
Table 6. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market 0.9% Sodium Chloride Intravenous Infusion Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of 0.9% Sodium Chloride Intravenous Infusion, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Product Type & Application
Table 12. Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 0.9% Sodium Chloride Intravenous Infusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 0.9% Sodium Chloride Intravenous Infusion as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2018-2024) & (K Unit)
Table 18. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Region (2018-2024)
Table 19. Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2024-2029) & (K Unit)
Table 20. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Region (2024-2029)
Table 21. Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Region (2018-2024)
Table 23. Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Region (2024-2029)
Table 25. North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2024) & (K Unit)
Table 27. North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2024-2029) & (K Unit)
Table 28. North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2024) & (K Unit)
Table 32. Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2024-2029) & (K Unit)
Table 33. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2018-2024) & (K Unit)
Table 37. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Region (2024-2029) & (K Unit)
Table 38. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2024) & (K Unit)
Table 42. Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2024-2029) & (K Unit)
Table 43. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2024) & (K Unit)
Table 47. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2024-2029) & (K Unit)
Table 48. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Type (2018-2024)
Table 51. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Type (2024-2029)
Table 52. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2018-2024)
Table 53. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2024-2029)
Table 54. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Type (2018-2024)
Table 55. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Type (2024-2029)
Table 56. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2018-2024)
Table 57. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2024-2029)
Table 58. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Type (2018-2024)
Table 59. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Type (2024-2029)
Table 60. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Application (2018-2024)
Table 61. Global 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit) by Application (2024-2029)
Table 62. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2018-2024)
Table 63. Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2024-2029)
Table 64. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Application (2018-2024)
Table 65. Global 0.9% Sodium Chloride Intravenous Infusion Revenue (US$ Million) by Application (2024-2029)
Table 66. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2018-2024)
Table 67. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2024-2029)
Table 68. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Application (2018-2024)
Table 69. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Application (2024-2029)
Table 70. Kelun Group Corporation Information
Table 71. Kelun Group Description and Business Overview
Table 72. Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product
Table 74. Kelun Group Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Baxter 0.9% Sodium Chloride Intravenous Infusion Product
Table 79. Baxter Recent Developments/Updates
Table 80. Fresenius Kabi Corporation Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Shijiazhuang No.4 Pharmaceutical Corporation Information
Table 86. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
Table 87. Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
Table 89. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
Table 90. CR Double-Crane Corporation Information
Table 91. CR Double-Crane Description and Business Overview
Table 92. CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product
Table 94. CR Double-Crane Recent Developments/Updates
Table 95. B.Braun Corporation Information
Table 96. B.Braun Description and Business Overview
Table 97. B.Braun 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. B.Braun 0.9% Sodium Chloride Intravenous Infusion Product
Table 99. B.Braun Recent Developments/Updates
Table 100. Otsuka Corporation Information
Table 101. Otsuka Description and Business Overview
Table 102. Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Otsuka 0.9% Sodium Chloride Intravenous Infusion Product
Table 104. Otsuka Recent Developments/Updates
Table 105. Cisen Pharmaceutical Corporation Information
Table 106. Cisen Pharmaceutical Description and Business Overview
Table 107. Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
Table 109. Cisen Pharmaceutical Recent Developments/Updates
Table 110. Hospira (ICU Medical) Corporation Information
Table 111. Hospira (ICU Medical) Description and Business Overview
Table 112. Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product
Table 114. Hospira (ICU Medical) Recent Developments/Updates
Table 115. Huaren Pharmaceuticals Corporation Information
Table 116. Huaren Pharmaceuticals Description and Business Overview
Table 117. Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product
Table 119. Huaren Pharmaceuticals Recent Developments/Updates
Table 120. Zhejiang Chimin Corporation Information
Table 121. Zhejiang Chimin Description and Business Overview
Table 122. Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product
Table 124. Zhejiang Chimin Recent Developments/Updates
Table 125. Dubang Pharmaceutical Corporation Information
Table 126. Dubang Pharmaceutical Description and Business Overview
Table 127. Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
Table 129. Dubang Pharmaceutical Recent Developments/Updates
Table 130. Guizhou Tiandi Corporation Information
Table 131. Guizhou Tiandi Description and Business Overview
Table 132. Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product
Table 134. Guizhou Tiandi Recent Developments/Updates
Table 135. Qidu Pharmaceutical Corporation Information
Table 136. Qidu Pharmaceutical Description and Business Overview
Table 137. Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product
Table 139. Qidu Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. 0.9% Sodium Chloride Intravenous Infusion Distributors List
Table 143. 0.9% Sodium Chloride Intravenous Infusion Customers List
Table 144. 0.9% Sodium Chloride Intravenous Infusion Market Trends
Table 145. 0.9% Sodium Chloride Intravenous Infusion Market Drivers
Table 146. 0.9% Sodium Chloride Intravenous Infusion Market Challenges
Table 147. 0.9% Sodium Chloride Intravenous Infusion Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 0.9% Sodium Chloride Intravenous Infusion
Figure 2. Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Type in 2022 & 2029
Figure 4. Flexible Bag Product Picture
Figure 5. Plastic Bottles Product Picture
Figure 6. Glass Bottle Product Picture
Figure 7. Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Other
Figure 12. Global 0.9% Sodium Chloride Intravenous Infusion Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global 0.9% Sodium Chloride Intravenous Infusion Market Size (2018-2029) & (US$ Million)
Figure 14. Global 0.9% Sodium Chloride Intravenous Infusion Sales (2018-2029) & (K Unit)
Figure 15. Global 0.9% Sodium Chloride Intravenous Infusion Average Price (US$/Unit) & (2018-2029)
Figure 16. 0.9% Sodium Chloride Intravenous Infusion Report Years Considered
Figure 17. 0.9% Sodium Chloride Intravenous Infusion Sales Share by Manufacturers in 2022
Figure 18. Global 0.9% Sodium Chloride Intravenous Infusion Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest 0.9% Sodium Chloride Intravenous Infusion Players: Market Share by Revenue in 2022
Figure 20. 0.9% Sodium Chloride Intravenous Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2018-2029)
Figure 23. North America 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2018-2029)
Figure 24. United States 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2018-2029)
Figure 27. Europe 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2018-2029)
Figure 28. Germany 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Region (2018-2029)
Figure 35. China 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2018-2029)
Figure 43. Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2018-2029)
Figure 44. Mexico 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Country (2018-2029)
Figure 49. Turkey 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE 0.9% Sodium Chloride Intravenous Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of 0.9% Sodium Chloride Intravenous Infusion by Type (2018-2029)
Figure 53. Global Revenue Market Share of 0.9% Sodium Chloride Intravenous Infusion by Type (2018-2029)
Figure 54. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of 0.9% Sodium Chloride Intravenous Infusion by Application (2018-2029)
Figure 56. Global Revenue Market Share of 0.9% Sodium Chloride Intravenous Infusion by Application (2018-2029)
Figure 57. Global 0.9% Sodium Chloride Intravenous Infusion Price (US$/Unit) by Application (2018-2029)
Figure 58. 0.9% Sodium Chloride Intravenous Infusion Value Chain
Figure 59. 0.9% Sodium Chloride Intravenous Infusion Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries